How stra(i)nge are your controls? A comparative analysis of metabolic phenotypes in commonly used C57BL/6 substrains.

Autor: Sil, Annesha¹ (AUTHOR) b.platt@abdn.ac.uk, Souza Matos, Marina¹ (AUTHOR), Delibegovic, Mirela¹ (AUTHOR), Platt, Bettina¹ (AUTHOR) b.platt@abdn.ac.uk

Publikováno v: PLoS ONE. 8/2/2023, Vol. 18 Issue 8, p1-15. 15p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The acoustic properties, syllable structure, and syllable sequences of ultrasonic vocalizations (USVs) during neonatal opioid withdrawal in FVB/N mouse substrains.

Autor: Wingfield KK; Laboratory of Addiction Genetics, Center for Drug Discovery, Department of Pharmaceutical Sciences, Northeastern University, Boston, MA USA.; T32 Biomolecular Pharmacology Training Program, Boston University Chobanian & Avedisian School of Medicine, Boston, MA USA., Misic T; Laboratory of Addiction Genetics, Center for Drug Discovery, Department of Pharmaceutical Sciences, Northeastern University, Boston, MA USA., Miracle SA; Laboratory of Addiction Genetics, Center for Drug Discovery, Department of Pharmaceutical Sciences, Northeastern University, Boston, MA USA.; Graduate Program for Neuroscience, Boston University, Boston, MA USA., McDermott CS; Laboratory of Addiction Genetics, Center for Drug Discovery, Department of Pharmaceutical Sciences, Northeastern University, Boston, MA USA., Jain K; Laboratory of Addiction Genetics, Center for Drug Discovery, Department of Pharmaceutical Sciences, Northeastern University, Boston, MA USA., Abney NM; Laboratory of Addiction Genetics, Center for Drug Discovery, Department of Pharmaceutical Sciences, Northeastern University, Boston, MA USA., Richardson KT; Laboratory of Addiction Genetics, Center for Drug Discovery, Department of Pharmaceutical Sciences, Northeastern University, Boston, MA USA.; Post-Baccalaureate Research Education Program, Boston University Chobanian & Avedisian School of Medicine., Rubman MB; NIH/NIDA Summer Undergraduate Fellowship Program., Beierle JA; T32 Biomolecular Pharmacology Training Program, Boston University Chobanian & Avedisian School of Medicine, Boston, MA USA.; Transformative Training Program in Addiction Science, Boston University Chobanian & Avedisian School of Medicine., Wachman EM; Department of Pediatrics, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Boston MA USA., Bryant CD; Laboratory of Addiction Genetics, Center for Drug Discovery, Department of Pharmaceutical Sciences, Northeastern University, Boston, MA USA.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Nov 07. Date of Electronic Publication: 2024 Nov 07.

Metabolic differences and differentially expressed genes between C57BL/6J and C57BL/6N mice substrains.

Autor: Nemoto, Shino¹ (AUTHOR) shino.nemoto@riken.jp, Kubota, Tetsuya^1,2,3,4,5 (AUTHOR), Ohno, Hiroshi^1,6,7 (AUTHOR)

Publikováno v: PLoS ONE. 12/22/2022, Vol. 17 Issue 12, p1-17. 17p.

Atp1a2 and Kcnj9 are candidate genes underlying sensitivity to oxycodone-induced locomotor activation and withdrawal-induced anxiety-like behaviors in C57BL/6 substrains.

Autor: Goldberg LR; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA.; Graduate Program in Biomolecular Pharmacology, Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA USA., Baskin BM; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA.; T32 Training Program on Development of Medications for Substance Use Disorder, Center for Drug Discovery, Northeastern University., Adla Y; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Beierle JA; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA.; Graduate Program in Biomolecular Pharmacology, Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA USA.; Transformative Training Program in Addiction Science, Boston University., Kelliher JC; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Yao EJ; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Kirkpatrick SL; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Reed ER; Graduate Program in Bioinformatics, Boston University, Boston, MA USA., Jenkins DF; Graduate Program in Bioinformatics, Boston University, Boston, MA USA., Cox J; Genetics and Graduate Program in Genetics and Genomics, Program in Biomedical Sciences, Boston University Chobanian & Avedisian School of Medicine., Luong AM; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Luttik KP; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Scotellaro JA; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA.; Undergraduate Research Opportunity Program (UROP), Boston University., Drescher TA; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Crotts SB; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Yazdani N; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA.; Graduate Program in Biomolecular Pharmacology, Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA USA.; Transformative Training Program in Addiction Science, Boston University., Ferris MT; Department of Genetics, University of North Carolina, Chapel Hill, NC USA., Johnson WE; Division of Infectious Disease, Department of Medicine, Center for Data Science, Rutgers University, New Jersey, USA., Mulligan MK; Department of Genetics, Genomics, and Informatics, University of Tennessee Health Science Center, Memphis, TN USA., Bryant CD; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA.; T32 Training Program on Development of Medications for Substance Use Disorder, Center for Drug Discovery, Northeastern University.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Sep 09. Date of Electronic Publication: 2024 Sep 09.